drugset / Trial / NCT00640952

Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease

NCT00640952

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine how many patients with Parkinson's disease have compulsive behaviors, and what types of behaviors they have. This study will also determine if acamprosate can be used to treat compulsive behaviors in Parkinson's disease patients.

Timeline

Start
2006-08
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Acamprosate Small molecule 333 mg

Indications